Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Reynolds

Showing results (431-440 of 482) with videos related to

Pageof 49
Sort By:
Translational Oncology|April 2, 2022
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinomaMaria Davern, Noel E Donlon, Fiona O' Connell, et al.
Neurology. Clinical Practice|August 26, 2024
An Interprofessional Team for Disease-Modifying Therapy in Alzheimer Disease ImplementationKatherine W Turk, Mark D Knobel, Alexandra Nothern, et al.
Irish Journal of Medical Science|March 17, 2021
Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemicJarlath C Bolger, Noel E Donlon, Waqas Butt, et al.
BMC Cancer|June 20, 2020
The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturationMaria E Morrissey, Róisín Byrne, Celina Nulty, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2022
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patientsMaria Davern, Noel E Donlon, Fiona O'Connell, et al.
Journal of Cancer Research and Clinical Oncology|November 29, 2022
Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapyMaria Davern, Noel E Donlon, Fiona O'Connell, et al.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Frontiers in Immunology|February 14, 2022
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint InhibitionNoel E Donlon, Maria Davern, Andrew D Sheppard, et al.
Cancers|November 18, 2020
Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for ChemokinesNoel E Donlon, Andrew Sheppard, Maria Davern, et al.
Irish Journal of Medical Science|July 23, 2020
Modern oncological and operative outcomes in oesophageal cancer: the St. James's hospital experienceNoel E Donlon, Narayanasamy Ravi, Sinead King, et al.
Pageof 49

Showing results (431-440 of 482) with videos related to

Sort By:
Pageof 49
Translational Oncology|April 2, 2022
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinomaMaria Davern, Noel E Donlon, Fiona O' Connell, et al.
Neurology. Clinical Practice|August 26, 2024
An Interprofessional Team for Disease-Modifying Therapy in Alzheimer Disease ImplementationKatherine W Turk, Mark D Knobel, Alexandra Nothern, et al.
Irish Journal of Medical Science|March 17, 2021
Successful maintenance of process and outcomes for oesophageal cancer surgery in Ireland during the first wave of the COVID-19 pandemicJarlath C Bolger, Noel E Donlon, Waqas Butt, et al.
BMC Cancer|June 20, 2020
The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturationMaria E Morrissey, Róisín Byrne, Celina Nulty, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2022
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patientsMaria Davern, Noel E Donlon, Fiona O'Connell, et al.
Journal of Cancer Research and Clinical Oncology|November 29, 2022
Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapyMaria Davern, Noel E Donlon, Fiona O'Connell, et al.
Translational Oncology|March 4, 2022
PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumoursMaria Davern, Marie-Claire Fitzgerald, Croí E Buckley, et al.
Frontiers in Immunology|February 14, 2022
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint InhibitionNoel E Donlon, Maria Davern, Andrew D Sheppard, et al.
Cancers|November 18, 2020
Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for ChemokinesNoel E Donlon, Andrew Sheppard, Maria Davern, et al.
Irish Journal of Medical Science|July 23, 2020
Modern oncological and operative outcomes in oesophageal cancer: the St. James's hospital experienceNoel E Donlon, Narayanasamy Ravi, Sinead King, et al.
Pageof 49